Trial Profile
Safety and efficacy of Emtricitabine/rilpivirine/tenofovir-disoproxil-fumarate (Eviplera) as a switch treatment option in HIV infected patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2015 New trial record